节点文献

替米沙坦片血药浓度的HPLC测定方法及其在健康人体的药动学研究

Pharmacokinetics of telmisartan tablets in healthy volunteers by HPLC

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 贾琳静温强乔海灵张启堂张莉蓉郭玉忠郜娜田鑫

【Author】 JIA Lin-Jing, WEN Qiang, QIAO Hai-Ling, ZHANG Qi-Tang, ZHANG Li-Rong, GUO Yu-Zhong, GAO Na, TIAN XinDepartment of Clinical Pharmacology, Medical College , Zhengzhou University, Zhengzhou 450052 , Henan, China

【机构】 郑州大学医学院临床药理学教研室郑州大学医学院临床药理学教研室 郑州 450052河南郑州 450052河南

【摘要】 目的:建立高效液相色谱法测定人血浆中替米沙坦的药物浓度,并研究其在健康人体内的药动学。方法:采用高效液相色谱-荧光检测法,色谱柱为Hypersil C18柱(250 mm×4.6 mm,5μm);流动相为乙腈-磷酸盐缓冲液(45∶55,pH 5.8);流速为1.0 ml·min-1;激发波长和发射波长分别为305 nm和365 nm;进样量20μl;内标物为α-萘酚。结果:替米沙坦在2~1 024μg·L-1范围内线性良好(r=0.9999),回收率,日间、日内差均符合生物样品分析要求。10名健康受试者口服替米沙坦片80 mg后的药动学结果表明,其体内过程符合二房室开放模型,主要药动学参数如下:Cmax为0.98±0.44 mg·L-1;Tmax为0.83±0.45 h;T1/2α为1.67±1.26 h;T1/2β为26.00±14.43 h;T1/2ka为0.53±0.86h;AUC0~t为3.66±2.10 mg·h-1·L-1;AUC0~∞为3.98±2.40 mg·h-1·L-1。结论:此方法便捷,准确,灵敏,适于替米沙坦血药浓度测定和药动学研究,本试验所得药动学参数可为临床合理用药提供理论依据。

【Abstract】 AIM: To establish an HPLC-fluorimetric method in determination of the concentrations of telmisar-tan in plasma of healthy volunteers and to investigate its pharmacokinetics. METHODS: The chromatographic column was Hypersil C18 column (250 mm×4.6 mm, 5μm) . The mobile phase was acetonitrile-pH 5.8 phosphate buffer (45 : 55) and the flow rate was 1.0 ml ·min-1 . The fluorimetric excitation and emission wavelengths were set at 305 nm and 365 run, respectively. The internal standard was α-naphthol. Blood samples were deproteined by adding acetonitrile. The injection volume was 20μl. RESULTS: The linearity correlation of telm-isartan ranged from 2 to 1 024 μg·L-1 ( r = 0.9999) and the precision and stability of the method were fine. The pharmacokinetics of telmisartan was studied in healthyvolunteers after oral administration of 80 mg telmisartan tablets. It showed that the c-t curves of telmisartan conformed to the two-compartment open model. The main pharmacokinetic parameters of telmisartan were as follow: Cmax0.98± 0.44 mg·L-1 Tmax0.83±0.45 h, T1/2α 1.67±1.26 h, T1/2β26.00±14.43 h, T1/2ka0.53±0.86 h, AUC0-t 3.66± 2.10 mg·h-1·L-1, and AUC0-∞ 3.98± 2.40 mg·h-1·L-1. CONCLUSION: This is a convenient, sensitive, accurate and reproducible method for determining the concentrations of telmisartan in plasma of healthy volunteers and investigating its pharma-cokinetics.

【关键词】 替米沙坦HPLC药动学血药浓度
【Key words】 telmisartanHPLCpharmacokineticsplasma concentrations
  • 【文献出处】 中国临床药理学与治疗学 ,Chinese Journal of Clinical Pharmacology and Therapeutics , 编辑部邮箱 ,2004年11期
  • 【分类号】R969.1
  • 【被引频次】2
  • 【下载频次】182
节点文献中: 

本文链接的文献网络图示:

本文的引文网络